Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allovir Inc ALVR

Healthcare Biotechnology
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life... see more

Recent & Breaking News (NDAQ:ALVR)

ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire January 26, 2024

ROSEN, NATIONAL TRIAL LAWYERS, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

TheNewsWire January 25, 2024

ROSEN, A TOP RANKED LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

Newsfile January 25, 2024

AlloVir, Inc. (ALVR) Investor Alert: Robbins LLP Reminds Stockholders of Class Action Against AlloVir, Inc.

Business Wire January 25, 2024

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 25, 2024

INVESTOR ALERT: Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire January 25, 2024

ALLOVIR INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options

PR Newswire January 25, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses to Contact the Firm

Accesswire January 25, 2024

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024

PR Newswire January 25, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire January 25, 2024

ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire January 25, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALVR

Accesswire January 24, 2024

ALLOVIR, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Filed in the United States District Court for the District of Massachusetts Against AlloVir, Inc.

Accesswire January 24, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 24, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR

Newsfile January 24, 2024

INVESTOR ALERT: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

Accesswire January 24, 2024

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Accesswire January 24, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire January 24, 2024

ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire January 24, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

TheNewsWire January 23, 2024